Augmedix, Inc. (NASDAQ:AUGX) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET
Company Participants
Matt Chesler - IR
Manny Krakaris - CEO
Paul Ginocchio - CFO
Conference Call Participants
Ryan Daniels - William Blair
Elizabeth Anderson - Evercore ISI
Aaron Wukmir - Lake Street Capital Markets
Yuan Zhi - B. Riley Securities
Allen Klee - Maxim Group
Bill Sutherland - The Benchmark Company
Operator
Ladies and gentlemen, greetings and welcome to the Augmedix, Inc. First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Matt Chesler, Investor Relations. Please go ahead.
Matt Chesler
Thank you, Operator. Joining me today are Manny Krakaris, Chief Executive Officer of Augmedix; and Paul Ginocchio, Chief Financial Officer.
This afternoon, we released financial results for the quarter ended March 31, 2024. We posted a copy of the press release and an investor presentation on our website at augmedix.com. We'll begin our call with prepared remarks to be followed by a Q&A session. This call is also being simulcast and will be archived on our website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements that relate to expectations or predictions of future events, results or performance are forward-looking statements. They are based upon our current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied.
Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors and Management's Discussion & Analysis in our most recent Form 10-K and Form 10-Q filed with the Securities and Exchange Commission and similar disclosures in subsequent reports filed with the SEC.
Also, during our call today, we will discuss non-GAAP financial measures, which adjust our GAAP results to eliminate the impact of certain items. You'll find additional information regarding these financial measures and a reconciliation to GAAP measures in today's press release.